Anti-RSK1 p90 (phospho T359) 抗体 [E238] (ab32413)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [E238] to RSK1 p90 (phospho T359)
- Suitable for: ELISA, WB, IHC-P, IP, Dot blot
- Reacts with: Mouse, Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-RSK1 p90 (phospho T359) antibody [E238]
RSK1 p90 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [E238] to RSK1 p90 (phospho T359) -
由来種
Rabbit -
特異性
This antibody is specific for human RSK1 p90 phoshorylated on Threonine 359. 80% identities with RSK3 p90 (pT365+pS369), 75% with RSK2 p90 (pT356+pS360) and 74% identities with RSK6 p90 (pT368+pS372)
-
アプリケーション
適用あり: ELISA, WB, IHC-P, IP, Dot blotmore details
適用なし: Flow Cyt or ICC/IF -
種交差性
交差種: Mouse, Human
交差が予測される動物種: Rat -
免疫原
Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- WB: A431 and NIH/3T3 cell lysates. IHC-P: Human cervical carcinoma tissue. IP: NIH/3T3 cell lysate
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
バッファー
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 49% PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
E238 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
- Anti-RSK1 p90 (phospho T359) antibody [E238] - BSA and Azide free (ab171376)
- PE Anti-RSK1 p90 (phospho T359) antibody [E238] (ab318320)
- APC Anti-RSK1 p90 (phospho T359) antibody [E238] (ab318423)
- Alexa Fluor® 488 Anti-RSK1 p90 (phospho T359) antibody [E238] (ab318526)
- Alexa Fluor® 647 Anti-RSK1 p90 (phospho T359) antibody [E238] (ab318629)
- Alexa Fluor® 594 Anti-RSK1 p90 (phospho T359) antibody [E238] (ab318732)
- Alexa Fluor® 555 Anti-RSK1 p90 (phospho T359) antibody [E238] (ab318832)
- Alexa Fluor® 750 Anti-RSK1 p90 (phospho T359) antibody [E238] (ab321601)
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
-
Related Products
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab32413の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ELISA |
Use a concentration of 0 - 1 µg/ml.
|
|
WB | (5) |
1/1000 - 1/10000. Detects a band of approximately 90 kDa (predicted molecular weight: 90 kDa).
|
IHC-P | (2) |
Use at an assay dependent concentration. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
|
IP |
1/100.
|
|
Dot blot |
1/1000.
|
特記事項 |
---|
ELISA
Use a concentration of 0 - 1 µg/ml. |
WB
1/1000 - 1/10000. Detects a band of approximately 90 kDa (predicted molecular weight: 90 kDa). |
IHC-P
Use at an assay dependent concentration. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
IP
1/100. |
Dot blot
1/1000. |
ターゲット情報
-
機能
Serine/threonine kinase that may play a role in mediating the growth-factor and stress induced activation of the transcription factor CREB. -
配列類似性
Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily.
Contains 1 AGC-kinase C-terminal domain.
Contains 2 protein kinase domains. -
翻訳後修飾
Autophosphorylated on Ser-380, as part of the activation process. - Information by UniProt
-
参照データベース
- Entrez Gene: 6195 Human
- Entrez Gene: 20111 Mouse
- Entrez Gene: 81771 Rat
- Omim: 601684 Human
- SwissProt: Q15418 Human
- SwissProt: P18653 Mouse
- SwissProt: Q63531 Rat
- Unigene: 149957 Human
see all -
別名
- 90 kDa ribosomal protein S6 kinase 1 antibody
- dJ590P13.1 (ribosomal protein S6 kinase, 90kD, polypeptide 1 antibody
- dJ590P13.1 antibody
see all
画像
-
All lanes : Anti-RSK1 p90 (phospho T359) antibody [E238] (ab32413) at 1/1000 dilution (purified)
Lane 1 : NIH/3T3 (mouse embryonic fibroblast) grown in serum free media for 4 hour swhole cell lysate
Lane 2 : NIH/3T3 grown in serum free media for 4 hours, then treated with 20% FBS for 30minutes whole cell lysate
Lane 3 : NIH/3T3 grown in serum free media for 4 hours, then treated with 20% FBS for 30 minutes whole cell lysate. Then the membrane was incubated with alkaline phosphatase
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution
Predicted band size: 90 kDa
Observed band size: 90 kDaBlocking/Diluting Buffer and concentration 5% NFDM/TBST
-
ELISA analysis using ab32413 at a range of 0-1000 ng/ml followed by a Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L)at 1/2500 dilution. Antigen concentration: 100 ng/ml.
Antigens: Human RSK1 p90 (phospho T359 + S363) peptide, Human RSK1 p90 (phospho T359) peptide, Human RSK1 p90 (phospho S363) peptide, Human RSK1 non-phospho peptide.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RSK1 p90 (phospho T359) antibody [E238] (ab32413)
Ab32413, at a 1/100 dilution, staining RSK1 p90 in paraffin embedded human cervical carcinoma tissue by Immunohistochemistry.
Left image : Untreated.
Right image : Treated with Phosphatase.Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
-
Purified ab32413 at 1/100 dilution (2µg) immunoprecipitating RSK1 p90 in NIH/3T3 whole cell lysate.
Lane 1 (input): NIH/3T3 (Mouse embryonic fibroblast) serum starved for 4h, then treated with 20% FBS for 30min whole cell lysate 10µg
Lane 2 (+): ab32413 + NIH/3T3 whole cell lysate.
Lane 3 (-): Rabbit monoclonal IgG (ab172730) instead of ab171376 in NIH/3T3 whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration: 5% NFDM/TBST.
Diluting buffer and concentration: 5% NFDM/TBST.
Observed band size: 90 kDa
Lower bands could be cleavage product. (PMID: 29290690) -
Dot blot analysis of RSK1 p90 (phospho T359 + S363) phospho peptide (Lane 1), RSK1 p90 phospho T359 phospho peptide (Lane 2), RSK1 p90 phospho S363 phospho peptide (Lane 3) and RSK1 p90 non-phospho peptide (Lane 4) labeling RSK1 p90 (phospho T359 + S363) phospho peptide with purified ab32413 at a dilution of 1/1000 dilution (2.056ug/ml). A Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) was used as the secondary antibody at a dilution of 1/20,000 dilution.
Blocking buffer: 5% NFDM/TBST. Dilution buffer: 5% NFDM /TBST .
-
All lanes : Anti-RSK1 p90 (phospho T359) antibody [E238] (ab32413) at 1/20000 dilution
Lane 1 : A431 cell lysate untreated.
Lane 2 : A431 cell lysate treated with EGF.
Predicted band size: 90 kDa
Observed band size: 90 kDa
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (24)
ab32413 は 24 報の論文で使用されています。
- Tian J et al. Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial. Nat Med 29:458-466 (2023). PubMed: 36702949
- Venkatanarayan A et al. CRAF dimerization with ARAF regulates KRAS-driven tumor growth. Cell Rep 38:110351 (2022). PubMed: 35139374
- Rao Q et al. Design, Synthesis, and Antileukemic Evaluation of a Novel Mikanolide Derivative Through the Ras/Raf/MEK/ERK Pathway. Front Pharmacol 13:809551 (2022). PubMed: 35721186
- Yu X et al. Rhein inhibits Chlamydia trachomatis infection by regulating pathogen-host cell. Front Public Health 10:1002029 (2022). PubMed: 36238249
- Ryan MB et al. KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy. Cell Rep 39:110993 (2022). PubMed: 35732135